1. THU0525 Safety of adalimumab ± methotrexate for the treatment of polyarticular juvenile idiopathic arthritis (PJIA): strive registry. (15th June 2017) Authors: Ruperto, N; Brunner, H; Nanda, K; Toth, M; Foeldvari, I; Bohnsack, J; Milojevic, D; Rabinovich, C; Kingsbury, D; Marzan, K; Quartier, P; Minden, K; Chalom, E; Horneff, G; Kuester, R; Dare, J; Bereswill, M; Kalabic, J; Kupper, H; Martini, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Issue 10315 (27th November 2021) Authors: Ruperto, Nicolino; Brunner, Hermine I; Synoverska, Olga; Ting, Tracy V; Mendoza, Carlos Abud; Spindler, Alberto; Vyzhga, Yulia; Marzan, Katherine; Grebenkina, Lyudmila; Tirosh, Irit; Imundo, Lisa; Jerath, Rita; Kingsbury, Daniel J; Sozeri, Betul; Vora, Sheetal S; Prahalad, Sampath; Zholobova, Ele... Journal: Lancet Issue: Volume 398:Issue 10315(2021) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗